Evidence map›Paper›PMID 22022532›Full record

ArticlePloS one2011

Fragile X related protein 1 clusters with ribosomes and messenger RNAs at a subset of dendritic spines in the mouse hippocampus.

Denise Cook, Maria del Rayo Sanchez-Carbente, Claude Lachance, Danuta Radzioch, Sandra Tremblay, Edouard W Khandjian, Luc DesGroseillers, Keith K Murai

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. The Prognostic and Therapeutic Potential of Fragile X Mental Retardation 1 (International journal of molecular sciences · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. FXR1 is elevated in colorectal cancer and acts as an oncogene.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  20. FXR1P is a GSK3β substrate regulating mood and emotion processing.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Denise CookDepartment of Neurology and Neurosurgery, The Research Institute of the McGill University Health Centre, Montreal General Hospital, Montreal, Quebec, Canada.
Maria del Rayo Sanchez-Carbente
Claude Lachance
Danuta Radzioch
Sandra Tremblay
Edouard W Khandjian
Luc DesGroseillers
Keith K Murai
McGill University · CAUniversité de Montréal · CAUniversité Laval · CAMcGill University Health Centre · CAMontreal General Hospital · CA

Funding

Role of TNFalpha in Synaptic Homeostasis in Response to Drugs of AbuseR21DA026053 · NIDA · MCGILL UNIVERSITY · PI MURAI, KEITH KAZUO, STELLWAGEN, DAVID · 2008 to 2009
$164k
CIHRNIDA NIH HHS 1R21DA026053-01NIDA NIH HHS R21 DA026053
6 · The paper itself

Abstract

The formation and storage of memories in neuronal networks relies on new protein synthesis, which can occur locally at synapses using translational machinery present in dendrites and at spines. These new proteins support long-lasting changes in synapse strength and size in response to high levels of synaptic activity. To ensure that proteins are made at the appropriate time and location to enable these synaptic changes, messenger RNA (mRNA) translation is tightly controlled by dendritic RNA-binding proteins. Fragile X Related Protein 1 (FXR1P) is an RNA-binding protein with high homology to Fragile X Mental Retardation Protein (FMRP) and is known to repress and activate mRNA translation in non-neuronal cells. However, unlike FMRP, very little is known about the role of FXR1P in the central nervous system. To understand if FXR1P is positioned to regulate local mRNA translation in dendrites and at synapses, we investigated the expression and targeting of FXR1P in developing hippocampal neurons in vivo and in vitro. We found that FXR1P was highly expressed during hippocampal development and co-localized with ribosomes and mRNAs in the dendrite and at a subset of spines in mouse hippocampal neurons. Our data indicate that FXR1P is properly positioned to control local protein synthesis in the dendrite and at synapses in the central nervous system.

Indexed as

AnimalsCluster AnalysisDendritic SpinesDisks Large Homolog 4 ProteinFemaleFragile X Messenger Ribonucleoprotein 1Green Fluorescent ProteinsGuanylate KinasesHEK293 CellsHippocampusHumansMaleMembrane ProteinsMiceMice, Inbred C57BLNeuronsDisks Large Homolog 4 ProteinDlg4 protein, mouseenhanced green fluorescent proteinFragile X Messenger Ribonucleoprotein 1Green Fluorescent ProteinsGuanylate KinasesMembrane ProteinsRecombinant Fusion ProteinsRNA, MessengerTissue Extracts

Identifiers

PMID22022532
PMCPMC3191184
OpenAlexW2045062124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.